About This Stock More About This StockReadReadReadRead
Article By: KKD Healthcare Analytics
Monday, April 24, 2017 10:03 AM EDT
Johnson & Johnson announced results from a Phase 2 clinical trial assessing the triple combination ofOlysio (simeprevir), C.R. Bard Inc. and Becton Dickinson finalize the deal for buying Bard.
Article By: Keith Park
Sunday, December 4, 2016 9:02 PM EDT
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolios.